- Joined
- Jan 9, 2019
- Messages
- 837
- Reaction score
- 1,180
“Initial board certification examination outcome (i.e., pass or fail) was assessed for a total of 15,171 candidates from Fall 2015 to Fall 2018. Pass rates for that period based on eligibility pathway (e.g., completion of a PGY-2 specialty residency, completion of a PGY-1 residency plus 1–2 years of postlicensure specialized practice experience, or 3–4 years of postlicensure specialized practice experience) were, respectively as follows: ambulatory care pharmacy (n = 2081): 94%, 84%, and 55% (P < 0.0001); critical care pharmacy (n = 2111): 99%, 94%, and 79% (P < 0.0001); oncology pharmacy (n = 1195) 93%, 75%, and 50% (P < 0.0001); pediatric pharmacy (n = 1119): 87%, 73%, and 57%; (P < 0.0001); pharmacotherapy (n = 8368): 88%, 59% (P < 0.0001); and psychiatric pharmacy (n = 477): 93%, 72%, 49% (P < 0.0001).“
Abstract found here: https://www.japha.org/article/S1544-3191(19)30291-2/fulltext
My takeaways:
1. APhA will definitely use this to push for PGY-2+ residencies.
2. This demonstrates that knowledge gained from residency trumps “working for a few years without residency” if BPS is used as the litmus test.
3. Sucks for retail pharmacists trying to get BPS certified as they likely have lower pass rates than that third bucket of candidates (relevant work experience with no residency) who are averaging something like a 50ish% pass rate across all specialties.
Abstract found here: https://www.japha.org/article/S1544-3191(19)30291-2/fulltext
My takeaways:
1. APhA will definitely use this to push for PGY-2+ residencies.
2. This demonstrates that knowledge gained from residency trumps “working for a few years without residency” if BPS is used as the litmus test.
3. Sucks for retail pharmacists trying to get BPS certified as they likely have lower pass rates than that third bucket of candidates (relevant work experience with no residency) who are averaging something like a 50ish% pass rate across all specialties.